BioAge Labs Inc. Share Price Today: Live Updates & Key Insights
BioAge Labs Inc. share price today is $22, up -0.59%. The stock opened at $22.005 against the previous close of $21.9, with an intraday high of $22.19 and low of $21.42.
BioAge Labs Inc. Share Price Chart
BioAge Labs Inc.
BioAge Labs Inc. Share Price Performance
BioAge Labs Inc. Institutional Holdings
BioAge Labs Inc. Market Status
BioAge Labs Inc. Fundamentals
Market Cap 973.51 M
PB Ratio 2.5702
PE Ratio 0.0
Enterprise Value 596.13 M
Total Assets 294.89 M
Volume 1031116
BioAge Labs Inc. Company Financials
About BioAge Labs Inc. & investment objective
Company Information BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Organisation Drug Manufacturers - Specialty & Generic
Employees 60
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Kristen Fortney Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
BioAge Labs Inc. FAQs
What is the share price of BioAge Labs Inc. today?
The current share price of BioAge Labs Inc. is $22.
Can I buy BioAge Labs Inc. shares in India?
Yes, Indian investors can buy BioAge Labs Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy BioAge Labs Inc. shares in India?
You can easily invest in BioAge Labs Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy BioAge Labs Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of BioAge Labs Inc..
Can I buy fractional shares of BioAge Labs Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of BioAge Labs Inc.?
BioAge Labs Inc. has a market cap of $973.51 M.
In which sector does BioAge Labs Inc. belong?
BioAge Labs Inc. operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in BioAge Labs Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of BioAge Labs Inc.?
The PE ratio of BioAge Labs Inc. is N/A and the PB ratio is 2.57.